Spots Global Cancer Trial Database for Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
Official Title: Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer
Study ID: NCT03071198
Conditions
Study Description
Brief Summary: Clinical effect of neoadjuvant hierarchical treatment based on chemotherapy for T3-4N0-2M0 middle and lower rectal cancer
Detailed Description: By setting 3-Year disease-free survival (DFS) as main objective, the treatment strategy will be optimizing as neoadjuvant chemotherapy alone and chemo-radio-chemo sequential treatment.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China
Contact Details
Name: binbin cui
Affiliation: Harbin Medical University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
